Contraception

Learn how clinicians can reduce pain during intrauterine device placement with evidence-based, patient-centered approaches to improve accessibility and patient experience.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent BMJ study reveals that hormonal contraceptives, particularly those containing oestrogen, may elevate the risk of ischemic stroke and heart attack, though absolute risks remain low.

A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.

Learn how complex contraceptive counseling helps individuals with medical conditions such as heart disease, lupus, and breast cancer find safe, effective birth control options tailored to their unique needs.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reveals shifts in contraceptive preferences, highlighting increased use of natural family planning, declining reliance on hormonal methods, and the need for better access to reliable information.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reported an increase in US young adults seeking permanent contraception methods following the Supreme Court’s Dobbs v Jackson Women's Health Organization decision in 2022, highlighting the need for accessible contraception.

Jason Bell, MD, discusses the impact of living in contraceptive deserts on college-aged women, highlighting the importance of education, access, and support for reproductive health.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.

A new study finds that intrauterine instillation of 2% mepivacaine significantly lowers pain levels during intrauterine device placement.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

With nearly half of short-acting contraceptive users preferring non-traditional sources such as telehealth and over-the-counter options, a recent study highlights evolving patient needs in contraceptive access.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Following the Dobbs v. Jackson ruling, more women are opting for permanent and long-acting contraceptive methods, even in states where abortion access remains protected.

Find out what’s new and what this means for your practice.

In a recent study, similar bone health results were reported between oral contraceptive users with and without prune consumption, as well as nonusers.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.

In a recent study, rates of 12-month or longer contraceptive supply were increased by the implementation of a 12-month contraceptive supply policy.

Following the Supreme Court’s decision to retain mifepristone access in June 2024, health care providers have spoken out about the need to fight for reproductive health care protections on a national and local level.